Anatomic Pathology
SKU
MRR-431F213C9077
Region
Global
Publication Date
March 2024
Delivery
Immediate
2023
USD 34.38 billion
2030
USD 57.27 billion
2024
USD 36.95 billion
CAGR
7.56%
Anatomic Pathology Market by Services (Cytopathology, Histopathology), Prōduct (Consumables, Instruments), Application, End User - Global Forecast 2024-2030

[193 Pages Report] The Anatomic Pathology Market size was estimated at USD 34.38 billion in 2023 and expected to reach USD 36.95 billion in 2024, at a CAGR 7.56% to reach USD 57.27 billion by 2030.

Anatomic Pathology Market
To learn more about this report, request a free sample copy
Anatomic pathology is a specialty in medical science concerned with diagnosing disease based on examining macroscopic, microscopic, biochemical, immunologic, and molecular structures of organs and tissues. It is critical in cancer diagnosis and guides treatment options for various diseases. The primary driving factors include the rising prevalence of chronic diseases and cancer worldwide, increasing demand for advanced diagnostic techniques, and the growing importance of personalized medicine. Technological advancements in anatomic pathology equipment, such as automation and high-throughput techniques, further adoption by enhancing efficiency and accuracy. However, the high cost of anatomic pathology instruments and a shortage of skilled professionals are significant restraints. Additionally, stringent regulatory frameworks in certain regions may impede its adoption by lengthening the approval process for new diagnostic tests and equipment. The primary challenges include integrating digital pathology systems within healthcare infrastructures and addressing data security and privacy concerns. Keeping pace with technological advancements and the need for continual education and training for pathologists and laboratory technicians also present significant hurdles. Opportunities include developing and adopting digital pathology and telepathology services, which can facilitate remote diagnoses and enable broader access to expert consultation. Furthermore, expanding healthcare infrastructure in emerging economies and increasing investments in healthcare and research present additional avenues.
Anatomic Pathology Market - Global Forecast 2024-2030
To learn more about this report, request a free sample copy
FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Anatomic Pathology Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Anatomic Pathology Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Anatomic Pathology Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc, Amos Scientific Pty Ltd, Bio SB, BioGenex Laboratories, Cardinal Health, Inc., Diapath S.p.A., Enzo Biochem, Inc., F. Hoffmann-La Roche Ltd., Histo-Line Laboratories, Milestone Medical, NeoGenomics Laboratories, Inc., PHC Holdings Corporation, RareCyte, Inc., Sakura Finetek USA, Inc., and VolitionRx Limited.

Market Segmentation & Coverage

This research report categorizes the Anatomic Pathology Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Services
    • Cytopathology
    • Histopathology
  • Prōduct
    • Consumables
      • Antibodies
      • Kits & Reagents
      • Probes
    • Instruments
      • Cell Processors
      • Coverslippers
      • Embedding Systems
      • Microtomes
      • Slide Staining Systems
      • Tissue Processing Systems
  • Application
    • Disease Diagnostics
    • Medical Research
  • End User
    • Clinical Laboratories
    • Hospital Laboratories

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Anatomic Pathology Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Anatomic Pathology Market?
  3. What are the technology trends and regulatory frameworks in the Anatomic Pathology Market?
  4. What is the market share of the leading vendors in the Anatomic Pathology Market?
  5. Which modes and strategic moves are suitable for entering the Anatomic Pathology Market?

Table of Contents
  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Anatomic Pathology Market, by Services
  7. Anatomic Pathology Market, by Prōduct
  8. Anatomic Pathology Market, by Application
  9. Anatomic Pathology Market, by End User
  10. Americas Anatomic Pathology Market
  11. Asia-Pacific Anatomic Pathology Market
  12. Europe, Middle East & Africa Anatomic Pathology Market
  13. Competitive Landscape
  14. Competitive Portfolio
Companies Mentioned
  • Agilent Technologies, Inc
  • Amos Scientific Pty Ltd
  • Bio SB
  • BioGenex Laboratories
  • Cardinal Health, Inc.
  • Diapath S.p.A.
  • Enzo Biochem, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Histo-Line Laboratories
  • Milestone Medical
  • NeoGenomics Laboratories, Inc.
  • PHC Holdings Corporation
  • RareCyte, Inc.
  • Sakura Finetek USA, Inc.
  • VolitionRx Limited
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.
Frequently Asked Questions about the Anatomic Pathology Market
The Global Anatomic Pathology Market size was estimated at USD 34.38 billion in 2023 and expected to reach USD 36.95 billion in 2024.
The Global Anatomic Pathology Market to grow USD 57.27 billion by 2030, at a CAGR of 7.56%
Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
We are approaching our 7th anniversary in 2024!
Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
Absolutely yes, with the purchase of additional user licenses.
Absolutely yes, so long as the 360iResearch cited correctly.